Covid-19 roundup: EU and As­traZeneca trade blows over slow­downs; Un­usu­al unions pop up to test an­ti­bod­ies, vac­cines

Af­ter com­ing un­der fire for man­u­fac­tur­ing de­lays last week, As­traZeneca’s feud with the Eu­ro­pean Union has spilled in­to the open.

The bloc ac­cused the phar­ma gi­ant on Wednes­day of pulling out of a meet­ing to dis­cuss cuts to its vac­cine sup­plies, the AP re­port­ed. As­traZeneca de­nied the re­ports, say­ing it still planned on at­tend­ing the dis­cus­sion.

Ear­ly Wednes­day, an EU Com­mis­sion spokes­woman said that “the rep­re­sen­ta­tive of As­traZeneca had an­nounced this morn­ing, had in­formed us this morn­ing that their par­tic­i­pa­tion is not con­firmed, is not hap­pen­ing.” But an As­traZeneca spokesper­son lat­er called the re­ports “not ac­cu­rate.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER